Epistaxis Prevention, Treatment, and Future Perspectives for Hereditary Hemorrhagic Telangiectasia.

Because the trial was underpowered, the primary outcome—the comparison of success rates defined as a ≥50% reduction in red blood cell (RBC) transfusions—did not reach statistical significance (63.6% vs. 33.3%).

also in 111,027 other papers